Antigen adsorbed surface modified poly-e{open}-caprolactone microspheres stimulates both adaptive and innate immune response in fish

Vaccine

Volumn 30, Issue 35, 2012, Pages 5278-5284

  Behera, Truptimayee ^a   Swain, Priyabrat ^a  

^a CENTRAL INSTITUTE OF FRESHWATER AQUACULTURE   (India)

Author keywords

Adjuvant; Alginate; Chitosan; Microspheres; Outer membrane vesicles; Parenteral immunization; Poly e open caprolactone; Vaccine

Indexed keywords

MICROSPHERE; POLYCAPROLACTONE;

ADAPTIVE IMMUNITY; ADSORPTION; ANIMAL EXPERIMENT; ANTIGEN FUNCTION; ARTICLE; CARP; EDWARDSIELLA TARDA; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; LABEO ROHITA; NONHUMAN; OUTER MEMBRANE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SURFACE PROPERTY;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ALGINATES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL VACCINES; CHITOSAN; EDWARDSIELLA TARDA; FISH DISEASES; FISHES; GLUCURONIC ACID; HEXURONIC ACIDS; IMMUNITY, INNATE; IMMUNIZATION; MICROSPHERES; PARTICLE SIZE; POLYESTERS;

EID: 84863839682     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.028     Document Type: Article

References (66)

1. Men Y., Thomasin C., Merkle H.P., Gander B., Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody response similar or superior to those obtained with aluminum hydroxide. Vaccine 1995, 13:683-689.
2. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release 1990, 11:205-214.
3. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol Immunol 1991, 28:287-294.
4. O'Hagan D.T., Jeffery H., Roberts M.J.J., McGee J.P., Davis S.S. Controlled release microparticles for vaccine development. Vaccine 1991, 9:768-771.
5. Behera T., Nanda P.K., Mohanty C., Mohapatra D., Swain P., Das B.K., et al. Parenteral immunization of fish, Labeo rohita with poly d,l-lactide-co-glycolic acid (PLGA) encapsulated antigen microparticle promotes innate and adaptive immune responses. Fish Shellfish Immunol 2010, 28:320-325.
6. Bramwell V.W., Perrie Y. Particulate delivery systems for vaccines: what can we expect. J Pharm Pharmacol 2006, 58:717-728.
7. Avramescu M.E., Borneman Z., Wessling M. Dynamic behavior of adsorbed membranes for protein recovery. Biotechnol Bioeng 2003, 84:564-572.
8. Hu J., Li S., Liu B. Adsorption of BSA onto sulfonated microspheres. J Biochem Eng 2005, 23:259-263.
9. Wu H., Sheng W., Huang F., Xiaoli Z., Jun Z., Ying W. Chitosan-polycaprolactone copolymer microspheres for transforming growth factor-β1 delivery. Colloid Surf B: Biointerface 2011, 82:602-608.
10. Singh J., Pandit S., Bramwell V.W., Alpar H.O. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods 2006, 38:96-105.
11. Baras B., Benoit M.A., Gillard J. Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen. J Microencapsul 2000, 17:485-498.
12. Baras B., Benoit M.A., Dupre L., Poulain-Godefroy O., Schacht A.M., Capron A., et al. Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infect Immunol 1999, 67:2643-2648.
13. Benoit M.A., Baras B., Gillard J. Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999, 184:73-84.
14. Lamprecht A., Ubrich N., Hombreiro P.M., Lehr C., Hoffman M., Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm 2000, 196:177-182.
15. Florindo H.F., Panditb S., Gonc L.M.D., Alparb H.O., Almeidaa A.J. Streptococcus equi antigens adsorbed onto surface modified poly-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine 2008, 26:4168-4177.
16. Visscher G.E., Robison M.A., Argentieri G.J. Tissue response to biodegradable injectable microcapsules. J Biomater Appl 1987, 2:118-131.
17. Conway B.R., Oya H.A. Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: effect of emulsifiers on microsphere characteristics and release kinetics. Eur J Pharm Biopharm 1996, 42:42-48.
18. Kohn J., Langer R. Bioresorbable and bioerodible materials. Biomaterials Science 1996, 64-72. Academic Press, San Diego. B. Ratner (Ed.).
19. Lemoine D., Francois C., Kedzierewicz F., Preat V., Hoffman M., Maincent P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide). Biomaterials 1996, 17:2191-2197.
20. Zhang L., Xiong C., Deng X. Biodegradable polyester blends for biomedical application. J Appl Polym Sci 1995, 56:103-112.
21. Qian H., Bei J., Wang S. Synthesis, characterization and degradation of ABA block copolymer of l-lactide and e{open}-caprolactone. Polym Degrad Stab 2000, 68:423-429.
22. Pitt C.G. Poly-caprolactone and its copolymers. Biodegradable Polymers as Drug Delivery Systems 1990, 71. Marcel Dekker, New York. R. Chasin, Langer (Eds.).
23. Lemmouchi Y., Schacht E., Lootens C. In vitro release of trypanocidal drugs from biodegradable implants based on poly (e{open}-caprolactone) and poly (d,l-lactide). J Control Release 1998, 55:79-85.
24. Miyajima M., Koshika A., Okada J., Ikeda M., Nishimura K. Effect of polymer crystallinity on papaverine release from poly(-lactic acid) matrix. J Control Release 1997, 49:207-215.
25. Gopalakanna A., Venkatesan A. Immunomodulatory effects of dietary intake of chitin, chitosan and levamisole on the immune system of Cyprinus carpio and control of Aeromonas hydrophila infection in ponds. Aquaculture 2006, 255:179-187.
26. Zheng C.H., Gao J.Q., Zhang Y.P., Liang W.Q. A protein delivery system: biodegradable alginate-chitosan-poly (lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun 2004, 323:1321-1327.
27. Potter A.A., Babiuk L.A. New approaches for antigen discovery, production and delivery: vaccines for veterinary and human use. Curr Drug Targets Infect Disord 2001, 1:249-262.
28. Rahman M.H., Kawai K. Outer membrane proteins of Aeromonas hydrophila induce protective immunity in goldfish. Fish Shellfish Immunol 2000, 10:379-382.
29. Ebanks R.O., Dacanay A., Goguen M., Pinto D.M., Ross N.W. Differential proteomic analysis of Aeromonas salmonicida outer membrane proteins in response to low iron and in vivo growth conditions. Proteomics 2004, 4:1074-1085.
30. Egusa S. Some bacterial diseases of freshwater fishes in Japan. Fish Pathol 1976, 10:103-114.
31. Janda J.M., Abbott S.L. Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease. Clin Infect Dis 1993, 17:742-748.
32. Kawai K., Liu Y., Ohnishi K., Oshima S. A conserved 37kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate. Vaccine 2004, 22:3411-3418.
33. Wang B., Mo Z.L., Xiao P., Li J., Zou Y.X., et al. EseD, a putative T3SS translocon component of Edwardsiella tarda, contributes to virulence in fish and is a candidate for vaccine development. Mar Biotechnol 2010, 12:678-685.
34. Sun Y., Liu C.S., Sun L. Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: subunit vaccine vs DNA vaccine. Vaccine 2011, 29:2051-2057.
35. Castro N., Toranzo A.E., Nuónçez S., Magarinços B. Development of an effective Edwardsiella tarda vaccine for cultured turbot (Scophthalmus maximus). Fish Shellfish Immunol 2008, 25:208-212.
36. Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Gene Dev 2005, 19:2645-2655.
37. Park S.B., Jang H.B., Nho S.W., Cha I.S., Jun-Ichi Hikima Ohtani M., Aoki T., et al. Outer membrane vesicles as a candidate vaccine against Edwardsiellosis. PLoS ONE 2011, 6:1-10.
38. Nakanishi T., Kiryu I., Ototake M. Development of a new vaccine delivery method for fish: percutaneous administration by immersion with application of a multiple puncture instrument. Vaccine 2002, 20:3764-3769.
39. Lusta K.A., Kozlovskii Y.E. Outer membrane nanovesicles of Gram negative bacteria Aeromonas hydrophila and Aeromonas salmonicida. Microbiology (© Pleiades Publishing, Ltd.) 2011, 80:519-524.
40. Swain P., Nayak S.K., Sahu A., Mohapatra B.C., Meher P.K. Bath immunization of spawns, fries and fingerlings of Indian major carps using a particulate antigen and determination of age, dose and duration of antigen exposure. Fish Shellfish Immunol 2002, 13:133-140.
41. Lund V., Jorgensen T., Holm K.O., Eggset G. Humoral immune response in Atlantic salmon, Salmo salar L., to cellular and extracellular antigens of Aeromonas salmonicida. J Fish Dis 1991, 14:443-452.
42. Quade M.J., Roth J.A. A rapid, direct assay to measure degranulation of bovine neutrophil primary granules. Vet Immun Immunopatho 1997, 58:239-248.
43. Anderson D.P., Siwicki A.K. Duration of protection against Aeromonas salmonicida in brook trout immunostimulated with glucan or chitosan by injection and immersion. Prog Fish Cult 1994, 56:258-261.
44. Sankaran K., Shanto G. On the variation in catalytic activity of lysozyme in fishes. Indian J Biochem Biophys 1972, 91:162-165.
45. Studnicka M., Siwicki A., Ryka B. Lysozyme level in carp (Cyprinus carpio L.). Isr J Aquacult 1986, 38:22-25.
46. Ellis A.E. Serum antiproteases in fish and lysozyme assays. Techniques in Fish Immunology 1990, 95-103. SOS Publications, Fair Haven, NJ. J.S. Stolen, T.C. Fletcher, D.P. Anderson, B.S. Roberson, W.B. van Muiswinkel (Eds.).
47. Magnado ttir B., Jonsdottir H., Helgason S., Bjornsson B., Jorgensen T.O., Pilstrom L. Humoral immune parameters in Atlantic cod (Gadus morhua L.). I. The effects of environmental temperature. Comp Biochem Physiol 1999, 122:173-180.
48. Blazer V.S., Wolke R.E. The effects of α-tocopherol on the immune response and non-specific resistance factors of rainbow trout (Salmo gairdneri Richardson). Aquaculture 1984, 37:1-9.
49. Reed L.J., Muench H. A simple method of estimating fifty percent end points. Am J Hyg 1938, 27:593-597.
50. SASR System for Regression 1991, SAS Institute Inc., SAS Institute Inc, Cary, NC, p. 210. 2nd ed.
51. Murillo M., Grillo M., Rene J., et al. A Brucella ovis antigenic complex bearing poly-e{open}-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine 2001, 19:4099-4106.
52. Conway M., Madrigal-Estebas L., McClean S., Brayden D., Mills K. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 2001, 19:1940-1950.
53. Jameela S.R., Suma N., Jayakrishnan A. Protein release from poly (epsiloncaprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J Biomater Sci Polym Ed 1997, 8:457-466.
54. Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H.P., et al. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 1999, 17:1047-1056.
55. Esparza I., Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992, 10:714-720.
56. Gong P., Szleifer I. Competitive adsorption of model charged proteins: the effect of total charge and charge distribution. J Colloid Interface Sci 2004, 278:81-90.
57. Avramescu M.E., Borneman Z., Wessling M. Dynamic behaviour of adsorbed membranes for protein recovery. Biotechnol Bioeng 2003, 84:564-572.
58. Mutoloki S., Reite O.B., Brudeseth B., Tverdal A., Evensen Q. A comparative immunopathological study of injection site reactions in salmonids following intraperitoneal injection with oil-adjuvanted vaccines. Vaccine 2006, 24:578-588.
59. Gjessing M.C., Falk K., Weli S.C., Koppang E.O., Kvellestad A. A sequential study of incomplete Freund's adjuvant-induced peritonitis in Atlantic cod. Fish Shellfish Immunol 2012, 32:141-150.
60. Anderson D.P. Immunostimulants, adjuvants and vaccine carrier in fish: applications to aquaculture. Annu Rev fish Dis 1992, 2:281-307.
61. Coombes A., Lavelle E., Jenkins P., Davis S. Single dose, polymeric, microparticle-based vaccines. The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 1996, 14:1429-1438.
62. Qian Y.X., Wang G.L., Shao J.Z. The non-specific immune regulation of fishes. Ningbo University learned. J Polytech Ed 2003, 13:95-99.
63. Fujiki K., Matsuyamas H., Yano T. Protective effect of sodium alginates against bacterial-infection in common Carp, Cyprinus-Carpio L. J Fish Dis 1994, 17:349-355.
64. Tian J.Y., Sun X.Q., Chen X.G. Formation and oral administration of alginate microspheres loaded with pDNA coding for lymphocystis diseases virus (LCDV) to Japanese flounder. Fish Shellfish Immunol 2008, 24:592-599.
65. Zaharoff D.A., Rogers C.J., Hance K.W., Schlom J., Greiner J.W. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2007, 25:2085-2094.
66. Venkataprasad N., Coombes A.G., Singh M., Rohde M., Wilkinson K., Hudecz F., et al. Induction of cellular immunity to amycobacterial antigen adsorbed on lamellar particles of lactide polymers. Vaccine 1999, 17:1814-1819.